Author:
Jain Lokesh,Gardner Erin R.,Venitz Jürgen,Dahut William,Figg William D.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference7 articles.
1. Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
2. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
3. The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006
4. M. Zhao, M.A. Rudek, P. He, F.T. Hafnerm, M. Radtke, J.J. Wright, B.D. Smith, W.A. Messersmith, M. Hidalgo, S.D. Baker, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 2006.
5. Guidelines for Industry: Bioanalytical Method Validation, http://www.fda.gov/CDER/GUIDANCE/4252fnl.htm, August 5, 2007.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献